Skip to main content
Collection

Pneumococcal vaccination programmes for infants, adults and individuals at increased clinical risk

Documents relating to the pneumococcal vaccination programmes for infants, adults and individuals at increased clinical risk.

Updates to this page

From:
UK Health Security Agency
Published:
13 December 2019
Last updated:
14 July 2026
Show all updates

  1. Added 'Pneumococcal vaccination: expansion of eligibility to people experiencing homelessness'.

  2. Pneumococcal vaccination for older adults and for individuals in a clinical risk group: Information for healthcare practitioners added to guidance section

  3. Added 'Change of vaccine for the routine adult pneumococcal vaccination programme and individuals at increased clinical risk' and 'Pneumococcal: the green book, chapter 25'.

  4. Out of date slideset for healthcare practitioners removed.

  5. Added 'pneumococcal vaccination: infant schedule changes from January 2020' letter.

  6. First published.

Pneumococcal vaccination programme for infants

From 1 July 2025 UK Health Security Agency (UKHSA) has made changes to the childhood immunisation schedule. Information about changes affecting other vaccines is published in the Changes to routine childhood immunisation programme: 2025 and 2026.

For more information, see the NHS page on pneumonia and Pneumococcal disease: guidance, data and analysis.

Peumococcal vaccination programme for adults and individuals at increased clinical risk

A change of vaccine for the routine pneumococcal vaccination programme for adults, for those aged 2 years and above in clinical risk groups for pneumococcal disease, and for children aged less than 2 years of age with asplenia, splenic dysfunction, complement disorder and severe immunosuppression.

In January/February 2026, PPV23 central supply will be run down and PCV20 will become available to order for the programme.

Guidance

Programme documents

Contents